New article: The affordances of electronic health management systems in the production of structural stigma

A new article led by DruGS team member Emily Lenton addresses the constitutive role of medical records in the production of stigma. Stemming from a research partnership developing novel strategies to address stigma related to blood-borne viruses and sexually transmissible infections in healthcare services, this new article analyses how the very process of producing medical…

Addressing BBV and STI-related stigma in healthcare: New resources for healthcare services now available

The DruGS team has recently published an implementation guide to support healthcare workers to use the blood-borne viruses (BBV) and sexually transmissible infections (STI) stigma reduction toolkit. In 2022 the team published the practice-ready stigma reduction toolkit designed to be used by individual healthcare professionals and services to tackle stigma and discrimination related to BBVs…

DruGS research showcased at 2023 CDP conference, Paris

In September, DruGS team members travelled to Paris, France, to take part in the Contemporary Drug Problems conference. Co-convened by the journal’s co-editors Associate Professor Kate Seear and Professor kylie valentine along with the conference organising committee, this year’s conference theme was ‘Embracing trouble: New ways of doing, being and knowing’. The theme aimed to…

DruGS program enters an exciting new phase

Following the recent retirements of Professor Suzanne Fraser (former DruGS Program Lead) and Professor David Moore (former DruGS Professorial Fellow), longtime DruGS team member Dr Adrian Farrugia has been announced as the new Program Lead. Aiming to continue their highly influential careers conducting theoretically innovative and empirically robust research on alcohol and other drugs and…

DruGS team to present research in Sweden and Portugal

November sees members of the DruGS Program travel to Europe to present a range of conference and seminar papers. DruGS Program Lead Professor Suzanne Fraser will present at a seminar hosted by Professor Mats Ekendahl (a DruGS Program collaborator) at the Department of Social Work, Stockholm University (8 November), and at the European Conference on…

Hepatitis C resources available free: Order now

One of the outcomes of the DruGS team’s Australian Research Council-funded project on the uptake of hepatitis C treatment in Australia is a collection of VitalvoicesonhepC.org resources. These are now being distributed for free to services and individuals. Launched on 31 May 2022 at the Australasian Viral Hepatitis Conference in Brisbane, VitalvoicesonhepC.org is a much-needed website that…

Major project outcome launched: VitalvoicesonhepC.org

What is hepatitis C? How does it feel to be diagnosed with it? What is it like to have treatment and be cured? A ground-breaking new website sheds light on the stories of people affected hepatitis C and explores their experiences of treatment and cure. Launched at the 2022 Viral Hepatitis conference in Brisbane on…

New article: Understanding the social and material basis for hepatitis C cure

A new article, led by DruGS program member Adrian Farrugia, reports findings from a national Australian Research Council-funded project on experiences of hepatitis C, treatment and cure since the advent of direct-acting antiviral treatment. The article, entitled ‘Hepatitis C cure as a “gathering”: Attending to the social and material relations of hepatitis C treatment’, analyses…

Launching Vital Voices website

In May, members of the DruGS team will attend the 13th annual Australasian Viral Hepatitis Conference (29 to 31 May). This conference is a key event for researchers, practitioners and policy makers working in viral hepatitis and related areas, and is an important opportunity to showcase key outcomes for our Australian Research Council-funded project, ‘Lived…

Telehealth for hepatitis C treatment during the pandemic: What works?

In 2021 the DruGS team conducted an Australian Government Department of Health-funded qualitative study on telehealth treatment for hepatitis C during the COVID-19 pandemic. The final report from the project has just been launched via webinar, and featured presentations on the findings and recommendations and a panel discussion spanning harm reduction and peer support, advocacy…